Episode Details
Back to EpisodesOsimertinib is a game changer in NSCLC
Episode 269
Published 3 years, 3 months ago
Description
How does lung cancer immunotherapy osimertinib affect 5-year survival? Find out about this and more in today's PV Roundup podcast.